Диссертация (1174340), страница 21
Текст из файла (страница 21)
Huang [et al.] // FetalDiagn. Ther. - 2014. – с.1-5.102. Stokowski R. Clinical performance of non-invasive prenatal testing(NIPT) using targeted cell-free DNA analysis in maternal plasma with microarraysor next generation sequencing (NGS) is consistent across multiple controlledclinical studies / R. Stokowski, E. Wang, K. White [et al.] // Prenat.
Diagn. – 2015.– Т. 35 – № 12– с.1243–1246.103. ZimmermannB. Noninvasive prenatal aneuploidy testing ofchromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphicloci. / B. Zimmermann, M. Hill, G. Gemelos [et al.] // Prenat. Diagn. – 2012. – Т.32 – № 13– с.1233–41.104. Samango-Sprouse C. SNP-based non-invasive prenatal testing detectssex chromosome aneuploidies with high accuracy.
/ C. Samango-Sprouse,M. Banjevic, A. Ryan [et al.] // Prenat. Diagn. – 2013. – Т. 33 – № 7– с.643–9.105. Agarwal A. Commercial landscape of noninvasive prenatal testing inthe United States / A. Agarwal, L. C. Sayres, M. K. Cho [et al.] // Prenat. Diagn. –2013. – Т. 33 – № 6– с.521–531.106.
Kalousek D.K. Chromosomal mosaicism confined to the placenta inhuman conceptions / D.K. Kalousek, F.J. Dill // Science - 1983. - T. 221– №4611– с.665–7.107. Phillips O.P. Risk of fetal mosaicism when placental mosaicism isdiagnosed by chorionic villus sampling. / O.P. Phillips, A.T. Tharapel, J.L. Lerner[et al.] / Am. J. Obstet. Gynecol.
- 1996. - T.174 - №3 – с.850-5.108. Malvestiti F. Interpreting mosaicism in chorionic villi: results of a131monocentric series of 1001 mosaics in chorionic villi with follow-upamniocentesis. / F. Malvestiti, C. Agrati, B. Grimi [et al.] // Prenat. Diagn. 2015. T. 35 - № 11 – с.1117-27.109. Gu S. Chromosomal microarray analysis on uncultured chorionicvillus sampling can be complicated by confined placental mosaicism foraneuploidy and microdeletions.
/ S. Gu, M. Jernegan, I.B. Van den Veyver [et al.]// Prenat. Diagn. – 2018. - T.38 - №11 – с.858-865.110. Choi H. Fetal aneuploidy screening by maternal plasma DNAsequencing: 'false positive' due to confined placental mosaicism./ H. Choi,T.K. Lau, F.M. Jiang [et al.] // Prenat. Diagn. - 2013. - T.33 - № 2 – с.198-200.111.
Hall A.L. Positive cell-free fetal DNA testing for trisomy 13 revealsconfined placental mosaicism. / A.L. Hall, H.M. Drendel, J.L. Verbrugge [et al.] //Genet. Med. - 2013. - T.15 - № 9 – с.729-32.112. Gardner R.J.M. Chromosome abnormalities and genetic counseling,3rd edn / Editors R.J.M. Gardner, G.R. Sutherland.
Oxford: Oxford UniversityPress, 2003. – с.577.113. Curnow K.J. Detection of triploid, molar, and vanishing twinpregnancies by a single-nucleotide polymorphism–based noninvasive prenatal test/ K. J. Curnow, L. Wilkins-Haug, A. Ryan [et al.] // Am. J. Obstet. Gynecol. –2015. – Т. 212 – № 1– с.79.e1-79.e9.114. Wang S. Maternal X chromosome copy number variations areassociated with discordant fetal sex chromosome aneuploidies detected bynoninvasive prenatal testing / S. Wang, S.
Huang, L. Ma [et al.] // Clin. Chim.Acta – 2015. – Т. 444– с.113–116.115. Russell L.M. X chromosome loss and ageing / L. M. Russell, P. Strike,C. E. Browne, P. A. Jacobs // Cytogenet. Genome Res.–2007. - Т. 116 - № 3 –с.181-185.116. Bayindir B. Noninvasive prenatal testing using a novel analysispipeline to screen for all autosomal fetal aneuploidies improves pregnancymanagement / B.
Bayindir, L. Dehaspe, N. Brison [et al.] // Eur J Hum Genet –1322015.117. Osborne C.M. Discordant noninvasive prenatal testing results in apatient subsequently diagnosed with metastatic disease / C. M. Osborne,E. Hardisty, P. Devers [et al.] // Prenat. Diagn. – 2013. – Т. 33 – № 6– с.609–611.118.
Dar P. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based non-invasive prenatal aneuploidy testing. / P. Dar,K. J. Curnow, S. J. Gross [et al.] // Am. J. Obstet. Gynecol. – 2014. - T. 211 - № 5– с.527.e1-527.e17.119. Jiang F. Noninvasive Fetal Trisomy (NIFTY) test: an advancednoninvasive prenatal diagnosis methodology for fetal autosomal and sexchromosomal aneuploidies. / F. Jiang, J. Ren, F. Chen [et al.] // BMC Med.Genomics - 2012. - Т. 5 – № 1- с.57.120. Nicolaides K.H. Assessment of Fetal Sex Chromosome AneuploidyUsing Directed Cell-Free DNA Analysis / K.
H. Nicolaides, T. J. Musci,C. A. Struble [et al.] // Fetal Diagn. Ther. – 2014. – Т. 35 – № 1– с.1–6.121. Norton M.E. Non-Invasive Chromosomal Evaluation (NICE) Study:results of a multicenter prospective cohort study for detection of fetal trisomy 21and trisomy 18. / M. E. Norton, H. Brar, J. Weiss [et al.] // Am. J. Obstet. Gynecol.– 2012. – Т. 207 – № 2– с.137.e1-8.122. Palomaki G.E. DNA sequencing of maternal plasma reliably identifiestrisomy 18 and trisomy 13 as well as Down syndrome: an internationalcollaborative study. / G.
E. Palomaki, C. Deciu, E. M. Kloza [et al.] // Genet. Med.– 2012. – Т. 14 – № 3– с.296–305.123. Palomaki G.E. DNA sequencing of maternal plasma to detect Downsyndrome: an international clinical validation study. / G. E. Palomaki,E.
M. Kloza, G. M. Lambert-Messerlian [et al.] // Genet. Med. – 2011. – Т. 13 –№ 11– с.913–20.124. Porreco R.P. Noninvasive prenatal screening for fetal trisomies 21, 18,13 and the common sex chromosome aneuploidies from maternal blood usingmassively parallel genomic sequencing of DNA / R. P.
Porreco, T. J. Garite,133K. Maurel [et al.] // Am. J. Obstet. Gynecol. – 2014. – Т. 211 – № 4– с.365.e1365.e12.125. Pettit K.E. The utilization of circulating cell-free fetal DNA testingand decrease in invasive diagnostic procedures: an institutional experience.
/K. E. Pettit, A. D. Hull, L. Korty [et al.] // J. Perinatol. – 2014. – Т. 34 – № 10–с.750–3.126. TheAmericanCollegeofObstetriciansandGynecologists.Noninvasive Prenatal Testing for Fetal Aneuploidy: Committee Opinion No. 545 /American College of Obstetricians and Gynecologists // Obs. Gynecol.
– 2012. –Т. 120– с.1532–1534.127. The American College of Obstetricians and Gynecologists (ACOG)Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy /ACOG // Obs. Gynecol. – 2015. – Т. 126 – № 3– с.e31-37.128. Zhang B. Noninvasive prenatal screening for fetal common sexchromosome aneuploidies from maternal blood / B. Zhang, B.-Y. Lu, B. Yu [etal.] // J. Int. Med.
Res. – 2017. – Т. 45 – № 2– с.621–630.129. McNamaraC.J. Maternal source of false-positive fetal sexchromosome aneuploidy in noninvasive prenatal testing. / C. J. McNamara,L. A. Limone, T. Westover, R. C. Miller // Obstet. Gynecol. – 2015. – Т. 125 –№ 2– с.390–2.130. Hartwig T.S. Discordant Non-Invasive Prenatal Testing (NIPT) - asystematic review / T. S. Hartwig, L. Ambye, S.
Sørensen, F. S. Jørgensen //Prenat. Diagn. - 2017. - Т.37 - №6 – с.527-539.131. Reiss R.E. Sex Chromosome Aneuploidy Detection by Non-InvasivePrenatal Testing: Helpful or Hazardous? / R. E. Reiss, M. Discenza, J. Foster [etal.] // Prenat. Diagn. – 2017. – T.37 - №5 – с.515-520.132. Liang D.
Non-invasive prenatal testing of fetal whole chromosomeaneuploidy by massively parallel sequencing. / D. Liang, W. Lv, H. Wang [et al.]// Prenat. Diagn. – 2013. – Т. 33 – № 5– с.409–15.133. Ma J. Birth of a child with trisomy 9 mosaicism syndrome associated134with paternal isodisomy 9: case of a positive noninvasive prenatal test resultunconfirmed by invasive prenatal diagnosis / J. Ma, D. S.
Cram, J. Zhang [et al.] //Mol. Cytogenet. – 2015. – Т. 8 – № 1– с.44.134. Yang J. A case of placental trisomy 18 mosaicism causing a falsenegative NIPT result / J. Yang, Y. Qi, F. Guo [et al.] // Mol. Cytogenet. – 2017. –Т. 10 – № 1– с.40.135. Reittinger A.M. A prenatal diagnosis of mosaic trisomy 5 reveals apostnatal complete uniparental disomy of chromosome 5 with multiple congenitalanomalies / A. M. Reittinger, B. M. Helm, D. J. Boles [et al.] // Am.
J. Med.Genet. Part A – 2017. – Т. 173 – № 9– с.2528–2533.136. Horn R. Opening Pandora’s box?: ethical issues in prenatal wholegenome and exome sequencing / R. Horn, M. Parker // Prenat. Diagn. – 2017. –с1–6.137. Wolstenholme J. Confined placental mosaicism for trisomies 2, 3, 7, 8,9, 16 and 22: Their incidence, likely origins, and mechanisms for cell lineagecompartmentalization / J. Wolstenholme // Prenat. Diagn. - 1996.
-Т.16 - №6с.511- 524.138. Bruns D.A. Twenty-five additional cases of trisomy 9 mosaic: Birthinformation, medical conditions, and developmental status / D. A. Bruns, E.Campbell // Am. J. Med. Genet. Part A – 2015. – Т. 167 – № 5– с.997–1007.139. Utermann B. Pre- and Postnatal Findings in Trisomy 17 Mosaicism /B. Utermann, M. Riegel, D. Leistritz [et al.] // Am. J. Med. Genet. – 2006. –Т.1636– с.1628–1636.140. Balbeur S. Trisomy rescue mechanism: the case of concomitantmosaic trisomy 14 and maternal uniparental disomy 14 in a 15-year-old girl. /S. Balbeur, B. Grisart, B.
Parmentier [et al.] // Clin. case reports – 2016. – Т. 4 –№ 3– с.265–271.141. Chareonsirisuthigul T. Intrauterine growth retardation fetus withtrisomy 16 mosaicism. / T. Chareonsirisuthigul, S. Worawichawong, R. Parinayok[et al.] // Case Rep. Genet. – 2014. – Т. 2014– с.739513.135142. ChenC.P.Prenataldiagnosisandmolecularcytogeneticcharacterization of low-level mosaic trisomy 12 at amniocentesis associated with afavorable pregnancy outcome / C. P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
